Dexmedetomidine on Brain Injury Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The aim of the study is to check whether dexmedetomidine has neuroprotective properties in brain injury patients. The enrolled 60 patients will be divided into two groups; Group 1(n=30): are the patients who will receive dexmedetomidine. Group 2 (n=30): are the patients who represent the control group.
Epistemonikos ID: df67ee94759ad2b31ce65e872c602dea75f106cf
First added on: Nov 01, 2024